Banned in Boston

April 6, 2009 by Chris Markuns

Massachusetts enacted the nation's strictest law governing industry payments to physicians. What does the so-called "gift ban" mean for the Commonwealth's medical devices sector?

Say goodbye to the promotional pen

Pharma is sexy. Big drugs, big money, big news. In the life sciences arena, perhaps only biotech commands a higher political and public profile.

So it isn’t surprising that the medical device industry’s groundbreaking inclusion in Massachusetts’ new code of conduct garnered relatively little attention.

But the new rules governing industry payments to physicians — the so-called "gift ban" — include provisions aimed at curbing what some call undue and improper influence by medical device manufacturers.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Features

Battelle engineering manager Melissa Masters tells MassDevice.com how insights ranging from national security to aeronautics can inform the creation of disruptive new medical devices.

The special sauce in contract research organization Ora Inc.'s recipe for ophthalmology trials is the eye care practice its founder started 30 years ago.

Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.

AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.

Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp